ZNTL - Zentalis Pharmaceuticals Llc - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

ZNTL is currently covered by 5 analysts with an average price target of $8.5. This is a potential upside of $7.14 (525%) from yesterday's end of day stock price of $1.36.

Zentalis Pharmaceuticals Llc's activity chart (see below) currently has 113 price targets and 112 ratings on display. The stock rating distribution of ZNTL is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 45.23% of the time, taking 119.95 days on average.

Highest price target for ZNTL is $10, Lowest price target is $6, average price target is $8.5.

Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 10-Nov-2026. First documented stock forecast 28-Apr-2020.

Best performing analysts who are covering ZNTL - Zentalis Pharmaceuticals Llc:

Andrew Fein Matthew Harrison Andrew Berens Biren Amin Michael Schmidt Robert Driscoll

Currently out of the existing stock ratings of ZNTL, 6 are a BUY (75%), 2 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 26-Jan-2025

$6

$4.64 (341.18%)

$4

11 days ago
(10-Nov-2026)

8/13 (61.54%)

$4.2 (233.33%)

181

Buy Since 27-Aug-2020

$10

$8.64 (635.29%)

$10

5 months 27 days ago
(25-May-2026)

3/17 (17.65%)

$5.94 (146.31%)

135

Buy Since 28-Apr-2020

$10

$8.64 (635.29%)

$6

7 months 11 days ago
(10-Apr-2026)

3/5 (60%)

$3.39 (51.29%)

160

Hold Since 10-Apr-2026

$6

$4.64 (341.18%)

$6

7 months 11 days ago
(10-Apr-2026)

2/6 (33.33%)

$-0.61 (-9.23%)

332

Buy Since 27-Mar-2026

$9

$7.64 (561.76%)

$10

7 months 25 days ago
(27-Mar-2026)

0/11 (0%)

$6.9 (328.57%)

Show more analysts

Please expand the browser size to see the chart

What is ZNTL (Zentalis Pharmaceuticals Llc) average time for price targets to be met?

On average it took 120 days for the stock forecasts to be reached, with an average price target met ratio of 45.23%.

Which analyst most recently updated their price target on ZNTL (Zentalis Pharmaceuticals Llc)?

Robert Driscoll

Which analyst has the most public recommendations on ZNTL (Zentalis Pharmaceuticals Llc)?

Robert Driscoll works at WEDBUSH and has 16 price targets and 13 ratings on ZNTL

Which analyst is the currently most bullish on ZNTL (Zentalis Pharmaceuticals Llc)?

Michael Ulz with the highest potential upside of $93.64

Which analyst is the currently most reserved on ZNTL (Zentalis Pharmaceuticals Llc)?

Eliana Merle with the lowest potential downside of -$1.84
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?